Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory
Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, citing a less favourable earnings trajectory as the drugmaker...
Newsbot
Mall retailer gets surprise $7 million bid amid bankruptcy
With Chapter 11 filings and mass store closures continuing to reshape Americas mall-based retail sector, its beginning to feel like old news. Brands including Altard State, Claires, Forever 21, and Francescas were once staples of local malls, becoming it-hangout spots and go-to destinations ...
Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss
AGIO beats fourth-quarter estimates for both the top and bottom lines as Pyrukynd sales jump 49% year over year.
Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory
Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, citing a less favourable earnings trajectory as the drugmaker...